On the stock exchanges, the Sensex on the Bombay Stock Exchange fell 524.96 points, or 0.89%, to close at 58,490.93, on Monday, September 20, 2021. The Nifty on the Stock Exchange Nacional fell 188.25 points, or 1.07%, to 17,396.90. . But certain stocks made the news after the market closed. These stocks may affect the indices when they reopen on Tuesday, September 21, 2021. List of these five stocks:
Watch Zee Business Live TV broadcast below:
Paras Defense IPO: The initial public offering (IPO) of Rs 170.7 crore of Paras Defense and Space Technologies Limited will open for tender today, i.e. September 21, 2021, and will close on Thursday, September 23. The price band for the defense company issue has been set at Rs 165-175 per share. The issue comprises a new issuance of Rs 140.6 million by the company and an offer to sell of up to 17.24,490 equity shares worth Rs 30 million by existing shareholders, including promoters of Paras. Defense. Retail investors can subscribe to the initial public offering by bidding on the 85 share lot and multiples of 85 thereafter. Additionally, Paras Defense and Space Technologies said on Monday that it has raised Rs 51.23 crore from anchor investors, ahead of its initial public offering (IPO) on Tuesday. The company has allocated 29,27,485 equity shares to anchor investors at 175 rupees each. Abakkus Emerging Fund (22.7%), HDFC Trustee (16.7%), Nippon Life (16.7%), Saint Capital Fund (9.76%) and Ashoka India Equity Investment Trust Plc (34.16%) participated in the anchor book.
SBI cards: Private equity firm Carlyle Group is looking to divest a 3.4% stake (about 3.2 crore shares) in SBI Cards and Payment Services worth $ 443 million (Rs 3,267.2 crore). The asking price has been set at Rs 1021 to Rs 1072 each, which is 4.6% off Monday’s closing price of Rs 1071.70 on the BSE. As of March 31, 2021, CA Rover Holdings had a 6.50% interest in the company.
Cadila + Pfizer
Cadila Healthcare: Zydus Healthcare Limited, a wholly owned subsidiary of the Company, signed an agreement on Monday with Integrace Private Limited to sell two brands viz. Mifegest and Cytolog.
Pfizer: The company said Monday that its COVID-19 vaccine works for children ages 5 to 11. The vaccine was safe for children during clinical trials.
Nestle: Suresh Narayanan, president and managing director of Nestlé India, a leader in food and beverages, has said that 2022 clearly appears to be a difficult year due to an increase in the prices of raw materials. Globally, the prices of coffee and edible oil have led to an increase in costs of 4 to 5%. The company has raised prices between 1 and 3 percent (depending on the categories). According to Narayanan, the growth of e-commerce is gradually slowing, while modern commerce has started to show traction among people on the go.
Kolte Patil: PGIM India Mutual Fund bought 500,000 shares at Rs 314.36 / share.
Windlas Biotech: Kuber India Fund sold 113,468 shares at Rs 379.73 / share.